CS Paper Radar

Concordance Plausibility Check for Intervention-Conditioned Human Digital Twins

Saeed Farzi, Christopher Kipps, John McBeth, Gabriela Czanner, Sofia Michopoulou, Benjamin Macarthur, Sarah Ennis, Paul Elkington, Nicholas C Harvey, Rahman Attar

cs.AI ·submitted 2026-10-17 09:15 UTC · v1

Abstract

Intervention-conditioned human digital twins predict treatment alternatives that cannot be observed in the same patient. Ordinary predictive accuracy therefore cannot establish counterfactual credibility. We propose the Concordance Plausibility Check (CPC), a claim-centered framework combining real-world evidence, qualified simulation and clinical knowledge. CPC matches evidence to the causal claim, audits contradictions and shared dependencies, and reports Pass, Fail or reason-coded Indeterminate.

Closest papers

Nearest neighbours by meaning across the whole index.

TwinGuard-Lite: A Rule-Based State-Admission Gateway for Generative Patient Digital Twins

cs.CR ·2026-10-06 ·Wenhui Chu, Sheikh Rabiul Islam
published similarity 0.59
Abstract · 6 pages, 2 figures, 1 table. Accepted to HealthSec'26 (Cybersecurity in Healthcare), co-located with ACSAC 2026

Future generative patient digital twins may combine longitudinal health records with language-model agents and keep information across sessions. The wording of a proposed update does not reveal whether it comes from an allowed source, conflicts with the patient's record, or belongs to someone else. We present TwinGuard-Lite, a rule-based gateway that admits an update to a twin's persistent state only if it passes checkable approximations of two integrity properties. Grounded state consistency (GSC) is approximated by a provenance check and a contradiction check; cross-patient noninterference (CPN) is approximated by a namespace check against trusted transport metadata. We evaluate three attack families over 20 seeded person-level splits of a semi-synthetic stream built from the openly licensed eICU database demo, with 29,131 $\pm$ 2706 candidate updates per seed. A keyword filter and an anomaly detector detect 16% and 24% of attacks, respectively; a provenance-only ablation detects 59.9% but misses every cross-patient attack. Combining GSC and CPN yields 99.1% precision, 90.5% recall, a 94.6% F1 score, and a 0.033% false-positive rate. Every attack the full gateway admits falsely claims a trusted source; when the retrieval channel does so, 92.9% of retrieval attacks are admitted. The results hold under stated trust assumptions, and no language model, agent, or retriever is executed: TwinGuard-Lite is a mechanism-level proof of concept that motivates authenticated, patient-bound ingestion, not a clinical safeguard.

0.41

When Can LLM Digital Twins Reduce Human Measurement? From Behavioral Fidelity to Statistical Substitutability

cs.AI stat.AP ·2026-09-07 ·Steven Wang, Kyle Hunt, Shaojie Tang, Kenneth Joseph
similarity 0.55
Abstract

LLM-based digital twins promise to reduce repeated human data collection by generating person- specific responses, yet existing evaluations provide little evidence about whether they can reduce human measurement while preserving valid inference. To address this, we introduce statistical substitutability, an inferential criterion that evaluates the extent to which twin predictions can reduce human measurement for a particular estimand while preserving valid inference. We develop a framework, grounded in mixed-subject and prediction-powered inference, that evaluates statistical substitutability along four dimensions: aggregate fidelity, paired respondent-level signal, finite-sample human-label recovery, and stability across populations. Across two empirical evaluations spanning behavioral experiments, multiple models, and alternative respondent representations, we find that digital twins can reproduce average human effects while providing little information about which individuals differ from those averages. Newer models and richer respondent information improve some dimensions of performance but do not reliably translate into human-data savings. Human calibration can reduce aggregate prediction error, yet limited labeled samples often fail to produce stable precision gains. Importantly, these findings demonstrate that behavioral fidelity is neither necessary nor sufficient for statistical substitutability. More broadly, they suggest that AI-generated evidence should be evaluated based on its ability to support valid scientific inference rather than its ability to reproduce human outcomes alone. Digital twins should therefore be judged for confirmatory use by whether they reduce uncertainty about human quantities, not merely by whether they reproduce human means, distributions, or effects.

0.61

Federated Bayesian Surveillance of Mechanical Thrombectomy Adverse Events: A Population Risk Layer for Surgical Digital Twins

cs.CR cs.RO ·2026-10-06 ·Damini Rijhwani
publishedbenchmarkunusual similarity 0.55
Abstract · Presented at the IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2026) Workshop on Surgical Digital Twins (SurgTwi…

Learned surgical simulators and world models can roll out plausible procedural futures, but they carry no grounded estimate of how often interventional devices actually harm patients. We propose treating population-scale adverse-event surveillance as a distinct belief layer of the surgical digital twin, and we evaluate a federated Bayesian protocol for learning it under formal privacy guarantees. Each site holds per-class Gamma-Poisson posteriors over adverse-event rates and exchanges only Rényi-differentially-private natural-parameter updates. We benchmark on the complete FDA MAUDE cohort for thrombus-retrieval catheters (product code NRY): 8,617 reports, of which 6,491 are classified by transparent keyword rules into five thrombectomy complication classes and partitioned across $K=8$ manufacturer sites. At a matched privacy budget of $(\\varepsilon \\approx 2.09, \δ= 10^{-5})$, the conjugate protocol attains a held-out Poisson score of -5.78 per test event versus -26.58 for FedAvg with differential privacy. The non-private federated model also outperforms centralized pooling (+3.19 vs +2.93), evidence that manufacturer-specific complication profiles are real and that federation preserves them. Because MAUDE lacks procedure denominators, outputs are relative rate orderings rather than absolute risks, and we report all privacy-utility operating points.

0.40

Intervention-Conditioned Counterfactual Human Digital Twin Generator

cs.LG q-bio.QM ·2026-10-09 ·Saeed Farzi, Sofia Michopoulou, Christopher Kipps, Rahman Attar
similarity 0.53
Abstract

Chronic diseases evolve through long, heterogeneous trajectories shaped by interacting mediators, confounders, and treatment histories. Estimating long-term patient trajectories under alternative interventions is essential for in silico clinical trial design. However, most existing models overlook irregular visit intervals and cross-mediator dependencies, both of which are crucial for reliable long-term longitudinal prediction. Moreover, these models typically focus on outcome prediction rather than generating complete patient-state trajectories. To address these challenges, we propose CHDT, an intervention-conditioned Human Digital Twin generator under standard identification assumptions for multimodal longitudinal trajectory estimation. Its main empirical advantage arises from explicit modeling of irregular visit intervals, while cross-mediator refinement provides additional gains in selected intervention-conditioned settings. Across real-world ADNI and simulator-generated ALPACA cohorts, CHDT shows improved long-horizon patient-state fidelity relative to competing baselines. Ablation results indicate that irregular-time conditioning provides the primary empirical gain, and cross-mediator refinement provides additional improvements.

0.11

When Reconstruction Is Not Enough: Doubly Robust Counterfactual and Interventional Mediation Analysis with Learned Multimodal Representations

cs.LG cs.AIstat.MEstat.ML ·2026-10-21 ·Cong Cao
publishedtheory similarity 0.53
Abstract · 22 pages, 1 table

Learned representations of high-dimensional multimodal health records are increasingly used to adjust for confounding, yet they are usually trained to reconstruct the data rather than preserve the information that causal identification requires. We study counterfactual outcomes under alternative treatments, including phenotype-specific effects and patient-level counterfactual risk profiles of the kind digital twins provide, and interventional direct and indirect effects under exposure-induced intermediate confounding. We give conditions under which a representation preserves identification and show that interventional mediation is more demanding than counterfactual comparison. We prove that no covariate-only training objective, whether reconstruction, contrastive, or physics-informed, can certify that a representation is sufficient, and that, in a linear structural model, a representation can lose arbitrarily little reconstruction accuracy yet induce arbitrarily large bias. We decompose the error of cross-fitted doubly robust estimators into a first-order representation bias, which neither double robustness nor cross-fitting removes, and a second-order remainder of nuisance-estimation errors, so coverage worsens as the sample size grows when the representation is insufficient. We propose a workflow combining modality-specific variational autoencoders trained outside the estimation sample, cross-fitted doubly robust estimators, locked phenotypes, select-then-confirm pathway analysis, portable representations, and diagnostics for representation insufficiency, exposure leakage, and sensitivity. In simulations, discarding a rare, moderately strong confounder gave indirect-effect intervals with 2% coverage at n = 3,000; reconstruction loss missed the problem, and a simple predictive diagnostic flagged it in every replicate.

0.46

TwinCheck: Evidence-Grounded Negative-Twin Verification for Stateful Tool Agents

cs.AI ·2026-09-22 ·Jiaxuan Dai, Tianyi Huang
published similarity 0.52
Abstract · Accepted at the NeurIPS 2026 Workshop Who Verifies the Agents? Toward Reliable Agent Development; Accepted at the NeurIPS 2026 Third Worksho…

A single locally plausible tool call can derail an otherwise successful agent trajectory. Suspicion alone does not justify intervention, because the replacement itself can introduce the very failure verification is meant to prevent. We introduce TwinCheck, an inference-time verification policy that considers replacement only when the trace satisfies an evidence condition tied to a trace-local failure hypothesis. It constructs a trace-grounded counterfactual alternative, a negative twin, and replaces the agent's proposal only if the twin passes structural checks and the pairwise verifier prefers it in both candidate orders. For paired evaluation, exact replay holds the agent's parsed responses and actions fixed until the first accepted replacement, separating intervention effects from resampling. In the primary analysis of 159 multi-turn BFCL V4 tasks with complete exact-replay pairs, the complete policy raises task success for GPT-5.6 Sol from 45.3% to 58.5% (95% task-bootstrap CI [8.2, 18.8]), with no observed success-to-failure regressions. Together, these findings recast execution-boundary repair as a constrained comparison, making the counterfactual action itself the object of verification.

0.58

Can AI Scientists Change Their Minds? Prior-Evidence Conflict in Synthetic Universes

cs.AI ·2026-09-29 ·Kargi Chauhan
benchmark similarity 0.52
Abstract

Can a scientific agent distinguish a law it inferred from evidence from one it merely recognizes? We introduce Synthetic Universes, a controlled benchmark that pairs canonical famous worlds with matched twisted twins governed by nearby noncanonical mechanisms. We evaluate each reported law twice: by executing it on held-out continuations and transfer settings, and by independently checking whether it recovers the generating mechanism. In the current checkpoint of a pre-specified 60-cell study, 22 trials were graded and one additional run ended in infrastructure failure. Among 20 twin trials, 8 pass predictive verification while 5 recover the generator. The dissociation is bidirectional: six parsable outputs predict successfully while missing the mechanism, whereas three recover the mechanism but fail predictive rollout. Drag exhibits the first pattern (5/5 predictive pass, 1/5 mechanism recovery); Gravity exhibits the second (1/5 predictive pass, 4/5 mechanism recovery). Because matched famous controls, the corrected identifiability sweep, and the Evidence Ladder remain incomplete, we do not claim a confirmatory causal prior-conflict effect. Instead, the completed runs establish a narrower verification result: predictive adequacy and mechanism recovery are distinct scientific claims and require distinct tests.

0.28

Evaluating Type-1 Diabetes Digital Twins by Decision Quality

cs.LG ·2026-10-22 ·Victor Li, Owen Tucker, Michael S. Hughes, Temiloluwa Prioleau, Shengpu Tang
code/data similarity 0.50
Abstract · 12 pages, 1 figure, 7 tables. Code: https://github.com/Veeeeeee7/T1D-Digital-Twin-Benchmark

A digital twin (DT) for type 1 diabetes (T1D) can predict how an individual's blood glucose will respond to different insulin treatments without actually trying them. For each treatment, downstream statistics of predicted glucose trajectories, such as glycemic risk, can be computed to guide clinical decisions. However, the quality of DTs is usually measured by the accuracy of their predicted glucose trajectories, which may not reflect the quality of the downstream treatment decisions they inform. In this work, we directly evaluate DTs by this decision quality on downstream treatment ranking, i.e., whether a DT predicts glucose trajectories that can be used to rank candidate treatments as the real patient would. We present an evaluation protocol over 30 virtual patients from the FDA-accepted UVA/Padova model, each simulated under 21 different basal-bolus treatments. For each patient, a DT is fitted under one treatment and then produces glucose trajectories for the remaining 20 treatments. Our results show that prediction accuracy and decision quality disagree. A baseline that models the average patient, never seeing the individual's glucose data, has the lowest prediction accuracy of all six methods (RMSE: 63.6 mg/dL) but ranks treatments with the second-highest mean Spearman (0.766), while a black-box neural network that predicts glucose nearly twice as accurately (RMSE: 32.9 mg/dL) ranks them no better than a random ordering of the 20 treatments (0.049 Spearman). Therefore, selecting a DT based on prediction accuracy alone can prefer one that recommends treatments at chance, and decision quality must be evaluated directly rather than assumed to follow from prediction accuracy.

0.34